603113.SS
603113.SS
CNE100002RK4
JINNENG SCIENCE AND TECHNOLOGY
Loading chart...
Elevated Business & Solvency Risk

Caution: In addition to price volatility, there are balance sheet risks due to higher debt or weaker liquidity (Health Score: 27/100).

Volatility Risk

Transparent evaluation of price volatility (SRI), Beta, and historical drawdowns.

Volatility Risk Score
7/7 Very High
7 / 7 SRI Price Fluctuation & Beta

Very high volatility or fundamental risks. Significant loss potential; strictly for aggressive investors. Moves noticeably less than the broader market (0.4x).

Beta (Market Relation)
0.36x
Defensive
Volatility (5Y p.a.)
37.1% p.a.
5-Year Horizon
Max Drawdown (5Y)
-77.8%
5-Year Horizon
Sharpe Ratio
-0.65
Return / Risk
Speculative / High Risk: Score Basis:

Multi-Horizon Risk & Performance Matrix

Historical volatility, drawdowns, and risk-adjusted return across 1, 3, 5, and 10 years.

Volatility Expansion (3Y > 5Y) High Volatility
Timeframe
Volatility (p.a.)
Max Drawdown
Sharpe Ratio
Return (p.a.)
1 Year — — — -26.4%
3 Years 39.4% -52.9% -0.44 -14.7%
5 Years 37.1% -77.8% -0.65 -21.2%
10 Years 43.1% -86.9% -0.36 —

Automated Risk & Health Notes (Red Flags)

Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Unprofitable business model: The company is currently generating net losses.
Strong cyclicality: The business model is sensitive to economic downturns.
🔴 Low analyst coverage – higher uncertainty in growth estimates & projections
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (37.1% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -86.9% in the extended horizon.
ende